Next Article in Journal
The “FIFTY SHADOWS” of the RALES Trial: Lessons about the Potential Risk of Dietary Potassium Supplementation in Patients with Chronic Kidney Disease
Next Article in Special Issue
Rituximab in Mucous Membrane Pemphigoid: A Monocentric Retrospective Study in 10 Patients with Severe/Refractory Disease
Previous Article in Journal
Gait Characterization and Analysis of Hereditary Amyloidosis Associated with Transthyretin Patients: A Case Series
Previous Article in Special Issue
Use of Dupilumab in Bullous Pemphigoid: Where Are We Now?
 
 
Review

Article Versions Notes

J. Clin. Med. 2022, 11(14), 3968; https://doi.org/10.3390/jcm11143968
Action Date Notes Link
article xml file uploaded 8 July 2022 08:34 CEST Original file -
article xml uploaded. 8 July 2022 08:34 CEST Update https://www.mdpi.com/2077-0383/11/14/3968/xml
article pdf uploaded. 8 July 2022 08:34 CEST Version of Record https://www.mdpi.com/2077-0383/11/14/3968/pdf
article html file updated 8 July 2022 08:35 CEST Original file -
article html file updated 13 August 2022 00:46 CEST Update https://www.mdpi.com/2077-0383/11/14/3968/html
Back to TopTop